«Management of NAFLD: a stage-based approach». Nature Reviews. Gastroenterology & Hepatology, 13, 4, 4-2016, pàg. 196–205. DOI: 10.1038/nrgastro.2016.3. PMID: 26907882.
«Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment». Journal of Gastroenterology and Hepatology, 33, 1, 1-2018, pàg. 70–85. DOI: 10.1111/jgh.13857. PMID: 28670712.
«The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups». Journal of Gastroenterology and Hepatology, 33, 1, 1-2018, pàg. 86–98. DOI: 10.1111/jgh.13856. PMID: 28692197.
«Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review». BMJ Open Gastroenterology, 4, 1, 01-06-2017, pàg. e000139. DOI: 10.1136/bmjgast-2017-000139. PMC: 5508801. PMID: 28761689.
«EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease». Journal of Hepatology, 64, 6, 6-2016, pàg. 1388–402. DOI: 10.1016/j.jhep.2015.11.004. PMID: 27062661.
Marjot, T; Moolla, A; Cobbold, JF; Hodson, L; Tomlinson, JW «Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management». Endocrine Reviews, 41, 1, 1-2020, pàg. bnz009. DOI: 10.1210/endrev/bnz009. PMID: 31629366.
«Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention». Nature Reviews. Gastroenterology & Hepatology, 15, 1, 1-2018, pàg. 11–20. DOI: 10.1038/nrgastro.2017.109. PMID: 28930295.
«Non-alcoholic fatty liver disease - A global public health perspective». Journal of Hepatology, 70, 3, 3-2019, pàg. 531–544. DOI: 10.1016/j.jhep.2018.10.033. PMID: 30414863.
«Fatty liver disease--a practical guide for GPs». Australian Family Physician, 42, 7, 7-2013, pàg. 444–7. PMID: 23826593.
«Management of NAFLD: a stage-based approach». Nature Reviews. Gastroenterology & Hepatology, 13, 4, 4-2016, pàg. 196–205. DOI: 10.1038/nrgastro.2016.3. PMID: 26907882.
«Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment». Journal of Gastroenterology and Hepatology, 33, 1, 1-2018, pàg. 70–85. DOI: 10.1111/jgh.13857. PMID: 28670712.
«The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups». Journal of Gastroenterology and Hepatology, 33, 1, 1-2018, pàg. 86–98. DOI: 10.1111/jgh.13856. PMID: 28692197.
«Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review». BMJ Open Gastroenterology, 4, 1, 01-06-2017, pàg. e000139. DOI: 10.1136/bmjgast-2017-000139. PMC: 5508801. PMID: 28761689.
«EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease». Journal of Hepatology, 64, 6, 6-2016, pàg. 1388–402. DOI: 10.1016/j.jhep.2015.11.004. PMID: 27062661.
Marjot, T; Moolla, A; Cobbold, JF; Hodson, L; Tomlinson, JW «Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management». Endocrine Reviews, 41, 1, 1-2020, pàg. bnz009. DOI: 10.1210/endrev/bnz009. PMID: 31629366.
«Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention». Nature Reviews. Gastroenterology & Hepatology, 15, 1, 1-2018, pàg. 11–20. DOI: 10.1038/nrgastro.2017.109. PMID: 28930295.
«Non-alcoholic fatty liver disease - A global public health perspective». Journal of Hepatology, 70, 3, 3-2019, pàg. 531–544. DOI: 10.1016/j.jhep.2018.10.033. PMID: 30414863.